38 results
8-K
EX-10.2
PSTX
Poseida Therapeutics Inc
7 Aug 23
Astellas and Poseida Therapeutics Announce Strategic
9:01am
. The Holders shall have the right to select one legal counsel to review and oversee any registration or matters pursuant to this Article II, including
DEF 14A
x6vrb
28 Apr 21
Definitive proxy
4:39pm
S-1
10m82
4 Jan 19
IPO registration
3:19pm
DRS/A
4t7x1yu158u7gz
27 May 20
Draft registration statement (amended)
12:00am
DRS
h00n6sjqz7q1
17 Apr 20
Draft registration statement
12:00am
424B4
kv8ogr1tdun0o cyge
10 Jul 20
Prospectus supplement with pricing info
4:55pm
DRS/A
1j4w976 ki1rwc
11 Dec 18
Draft registration statement (amended)
12:00am
DRS
b5wgo6y0p92fl2k4u02
1 Nov 18
Draft registration statement
12:00am
S-1
EX-10.13
g3llfr 9t4x9u
4 Jan 19
IPO registration
3:19pm
DRS
EX-10.16
65ou22t b5w5h0x7
17 Apr 20
Draft registration statement
12:00am